Siham Farhane

504 total citations
7 papers, 162 citations indexed

About

Siham Farhane is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Siham Farhane has authored 7 papers receiving a total of 162 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Immunology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Siham Farhane's work include Cancer Immunotherapy and Biomarkers (7 papers), Immunotherapy and Immune Responses (4 papers) and CAR-T cell therapy research (3 papers). Siham Farhane is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Immunotherapy and Immune Responses (4 papers) and CAR-T cell therapy research (3 papers). Siham Farhane collaborates with scholars based in France, Canada and United States. Siham Farhane's co-authors include Samy Ammari, Aurélien Marabelle, Caroline Robert, Stéphane Champiat, Thierry de Baère, Lambros Tselikas, Émilie Lanoy, Christophe Massard, Matthieu Texier and Fabrice Barlési and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and European Journal of Cancer.

In The Last Decade

Siham Farhane

7 papers receiving 157 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Siham Farhane France 6 105 70 27 25 20 7 162
Yvonne S.L. Mak United States 4 114 1.1× 57 0.8× 26 1.0× 58 2.3× 19 0.9× 5 195
Rachel Marcone Switzerland 5 95 0.9× 100 1.4× 15 0.6× 54 2.2× 11 0.6× 9 163
Florian Märkl Germany 4 97 0.9× 88 1.3× 22 0.8× 29 1.2× 13 0.7× 8 140
Phil Vourtzoumis Canada 5 112 1.1× 256 3.7× 39 1.4× 64 2.6× 31 1.6× 9 340
Kristi L. Manjarrez United States 7 109 1.0× 182 2.6× 7 0.3× 50 2.0× 31 1.6× 19 254
Alissa Keegan United States 7 137 1.3× 68 1.0× 15 0.6× 39 1.6× 55 2.8× 14 202
Gabriella Lionetto Italy 7 95 0.9× 49 0.7× 17 0.6× 12 0.5× 27 1.4× 24 142
Boyu Hu United States 9 122 1.2× 52 0.7× 12 0.4× 64 2.6× 12 0.6× 34 210
Whitney Tamaki United States 4 51 0.5× 122 1.7× 15 0.6× 57 2.3× 11 0.6× 5 217
Ian Lewis United Kingdom 6 57 0.5× 31 0.4× 6 0.2× 50 2.0× 23 1.1× 11 141

Countries citing papers authored by Siham Farhane

Since Specialization
Citations

This map shows the geographic impact of Siham Farhane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siham Farhane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siham Farhane more than expected).

Fields of papers citing papers by Siham Farhane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siham Farhane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siham Farhane. The network helps show where Siham Farhane may publish in the future.

Co-authorship network of co-authors of Siham Farhane

This figure shows the co-authorship network connecting the top 25 collaborators of Siham Farhane. A scholar is included among the top collaborators of Siham Farhane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siham Farhane. Siham Farhane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Ghosn, Mario, Lambros Tselikas, Stéphane Champiat, et al.. (2023). Intratumoral Immunotherapy: Is It Ready for Prime Time?. Current Oncology Reports. 25(8). 857–867. 10 indexed citations
2.
Decazes, Pierre, Samy Ammari, Hugues Talbot, et al.. (2023). Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer. Journal for ImmunoTherapy of Cancer. 11(9). e007315–e007315. 9 indexed citations
3.
Talbot, Hugues, Nathalie Lassau, Siham Farhane, et al.. (2023). Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy. Clinical Cancer Research. 29(8). 1528–1534. 2 indexed citations
4.
Antoun, S., Émilie Lanoy, Samy Ammari, et al.. (2022). Protective effect of obesity on survival in cancers treated with immunotherapy vanishes when controlling for type of cancer, weight loss and reduced skeletal muscle. European Journal of Cancer. 178. 49–59. 23 indexed citations
5.
Tselikas, Lambros, Stéphane Champiat, Rahul A. Sheth, et al.. (2021). Interventional Radiology for Local Immunotherapy in Oncology. Clinical Cancer Research. 27(10). 2698–2705. 26 indexed citations
6.
Tselikas, Lambros, Caroline Robert, Stéphane Dalle, et al.. (2021). 277 Safety and efficacy of intratumoral ipilimumab with IV nivolumab in metastatic melanoma. The NIVIPIT trial. SHILAP Revista de lepidopterología. A300–A300. 6 indexed citations
7.
Champiat, Stéphane, Lambros Tselikas, Siham Farhane, et al.. (2020). Intratumoral Immunotherapy: From Trial Design to Clinical Practice. Clinical Cancer Research. 27(3). 665–679. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026